Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysisThi Lien-Anh Nguyên, John Hiscott, Simon Léveillé et al.|Proceedings of the National Academy of Sciences|2008Cited by 182
Model-based rational design of an oncolytic virus with improved therapeutic potentialFabrice Le Bœuf, John C. Bell, Cory Batenchuk et al.|Nature Communications|2013Cited by 44